Second Sight Medical (EYES) Reports Q2 Loss of $0.14
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall St set for higher open as Democrats win Congress; data center stocks slide
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
Tweet
Share
E-mailGet Alerts EYES Hot Sheet
Join SI Premium – FREE
Second Sight Medical (NASDAQ: EYES) reported Q2 EPS of ($0.14), versus ($0.32) reported last year. Revenue for the quarter came in at $2.7 million, versus $600 thousand reported last year.
For earnings history and earnings-related data on Second Sight Medical (EYES) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- McDonald's posts better-than-expected third-quarter comparable sales
- Datadog stock tumbles 19% despite earnings beat
- Natural Resource Partners (NRP) Reports Q3 EPS of $1.95
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
